SG Americas Securities’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$530K	Buy	9,119 +2,042	+29%	+$94.1K	﹤0.01%	2152
2025 Q4	$317K	Buy	7,077 +149	+2%	+$6.26K	﹤0.01%	2727
2025 Q3	$278K	Sell	6,928 -12,249	-64%	-$431K	﹤0.01%	2541
2025 Q2	$600K	Buy	19,177 +10,522	+122%	+$343K	﹤0.01%	1537
2025 Q1	$290K	Sell	8,655 -4,638	-35%	-$176K	﹤0.01%	2238
2024 Q4	$521K	Buy	13,293 +5,577	+72%	+$231K	﹤0.01%	1310
2024 Q3	$304K	Sell	7,716 -18,463	-71%	-$744K	﹤0.01%	2139
2024 Q2	$1.02M	Buy	26,179 +5,813	+29%	+$232K	0.01%	1290
2024 Q1	$877K	Buy	20,366 +1,760	+9%	+$81K	﹤0.01%	1185
2023 Q4	$857K	Sell	18,606 -38,146	-67%	-$1.35M	0.01%	1111
2023 Q3	$1.94M	Buy	56,752 +17,490	+45%	+$654K	0.03%	754
2023 Q2	$1.51M	Buy	39,262 +13,385	+52%	+$532K	0.01%	867
2023 Q1	$926K	Sell	25,877 -9,588	-27%	-$354K	0.01%	1187
2022 Q4	$1.4M	Buy	35,465 +13,633	+62%	+$496K	0.02%	758
2022 Q3	$788K	Sell	21,832 -621	-3%	-$22.3K	0.01%	1184
2022 Q2	$683K	Buy	+22,453	New	+$679K	0.01%	1670